Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States is a research paper published in Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Office of Naval Research
Grant: N00014‐18‐1‐2850
Office of Naval Research
Grant: N00014‐18‐1‐2888
Office of Naval Research
Grant: N00014‐20‐1‐2705
Health Resources and Services Administration
Grant: HHSH250201700006C
Health Resources and Services Administration
Grant: HHSH250201700007C
Health Resources and Services Administration
Grant: SC1MC31881‐01‐00
National Heart, Lung, and Blood Institute
Grant: R21HL140314
National Heart, Lung, and Blood Institute
Grant: U01HL128568
National Cancer Institute
Grant: R01‐CA215134
National Institutes of Health
Grant: P30 CA016672
NHLBI NIH HHS
Grant: R01 HL130388
NIAID NIH HHS
Grant: U01 AI069197
Office of Naval Research
Grant: N00014-18-1-2888
NCI NIH HHS
Grant: P01 CA111412
Health Resources and Services Administration (HRSA)
Grant: SC1MC31881-01-00
NCI NIH HHS
Grant: U24 CA076518
Office of Naval Research
Grant: N00014-18-1-2850
Office of Naval Research
Grant: N00014-20-1-2705
NCI NIH HHS
Grant: R01 CA152108
NHLBI NIH HHS
Grant: R01 HL129472
NHLBI NIH HHS
Grant: K23 HL150232
NIAID NIH HHS
Grant: R01 AI128775
NHLBI NIH HHS
Grant: R01 HL131731
NCI NIH HHS
Grant: R01 CA215134
NHLBI NIH HHS
Grant: R01 HL126589
NCI NIH HHS
Grant: U01 CA246659
NCI NIH HHS
Grant: R01 CA218285
NCI NIH HHS
Grant: R01 CA231141
NIAID NIH HHS
Grant: U01 AI126612
NHLBI NIH HHS
Grant: U24 HL138660
CytoSen Therapeutics
GlaxoSmithKline
Terumo BCT
Actinium Pharmaceuticals
Daiichi-Sankyo
Janssen Pharmaceuticals
Mesoblast
Sanofi Genzyme
AbbVie
Amgen
CSL Behring
Jazz Pharmaceuticals
Magenta Therapeutics
Merck Sharp and Dohme
Orca Biosystems, Inc
Pharmacyclics, LLC
Xenikos BV
AlloVir
Astellas Pharma US
Daiichi Sankyo Co
Gamida-Cell
Incyte Corporation
Mallinckrodt LLC
Seattle Genetics
Sobi, Inc
Adienne SA
Genzyme
Medical College of Wisconsin
Miltenyi Biotec
Pfizer
Takeda Oncology
Takeda Pharma
Adaptive Biotechnologies
AstraZeneca
Kiadis Pharma
Kite Pharma
Kyowa Kirin
Merck
Merck & Company, Inc
Millennium (the Takeda Oncology Co)
Novartis Oncology
Omeros Corporation
Regeneron Pharmaceuticals
Viracor Eurofins
Bristol-Myers Squibb
Chimerix
HistoGenetics
Medac GmbH
Merck Sharp & Dohme Corp
Takeda Pharmaceuticals U.S.A.
Anthem
Atara Biotherapeutics
Bluebird Bio
Celgene
Janssen Biotech
Janssen/Johnson & Johnson
Kyowa Hakko Kirin
Legend Biotech
Novartis Pharmaceuticals Corporation
OncoImmune, Inc
REGiMMUNE Corp
Sanofi Genzyme
Adaptive Biotechnologies
Terumo BCT
Sobi, Inc
Novartis Oncology
Kyowa Kirin
Genzyme
Janssen/Johnson & Johnson
OncoImmune, Inc
Orca Biosystems, Inc
Mesoblast
Regeneron Pharmaceuticals
Kite Pharma
HistoGenetics
Daiichi Sankyo Co
Bluebird Bio
Actinium Pharmaceuticals
Millennium (the Takeda Oncology Co)
AlloVir
Jazz Pharmaceuticals
AstraZeneca
Adienne SA
Kiadis Pharma
Amgen
Medical College of Wisconsin
Novartis Pharmaceuticals Corporation
Gamida-Cell
Incyte Corporation
Pharmacyclics, LLC
Janssen Biotech
CytoSen Therapeutics
Viracor Eurofins
REGiMMUNE Corp
Astellas Pharma US
Takeda Oncology
AbbVie
Seattle Genetics
Celgene
Merck & Company, Inc
Bristol-Myers Squibb
Miltenyi Biotec
Anthem
Chimerix
Atara Biotherapeutics
Pfizer
CSL Behring
Medac GmbH
GlaxoSmithKline
Janssen Pharmaceuticals
Legend Biotech
Merck Sharp & Dohme Corp
Xenikos BV
Takeda Pharma
Omeros Corporation
Mallinckrodt LLC
Magenta Therapeutics
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals